Scientists from St. Jude Children’s Research Hospital, Seattle Children’s and the Children’s Oncology Group (COG), USA, have identified novel...
Vous n'êtes pas connecté
To help accelerate research into new treatments for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the
Scientists from St. Jude Children’s Research Hospital, Seattle Children’s and the Children’s Oncology Group (COG), USA, have identified novel...
MONDAY, Aug. 19, 2024 -- Older patients with acute myeloid leukemia (AML) have high health care utilization and poor survival outcomes, according to...
CHENGDU, China, Aug. 8, 2024. WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND...
Competitive: Stanford University (US): Cancer Clinical Research Coordinator Associate - Radiation Oncology (Hybrid) The Stanford Cancer Institute...
TUESDAY, Aug. 13, 2024 -- Routine clinical laboratory values do not serve as biomarkers for postacute sequelae of severe acute respiratory syndrome...
Competitive: Parexel: If you want to be part of a leading CRO and transform scientific discoveries into new treatments, then Parexel FSP challenges...
One of WA’s biggest-ever philanthropic donations will transform childhood cancer research in the State by finding more effective and less toxic...
Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
Youth in Kenya have been urged to engage in scientific research that fuels progress and drives innovation in the country. Speaking during the...
Competitive: ICON Plc: ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance...